Genetics and Coronary Artery Disease: Key Insights
Genetics and Coronary Artery Disease: Key Insights One crucial genetic risk factor is familial hypercholesterolemia, a condition characterized by high levels of LDL cholesterol. Individuals with familial hypercholesterolemia have an increased risk of developing CAD at an early age. Studying the genetics of CAD also helps us comprehend the role of hereditary heart disease in its manifestation.
Genetic testing is a powerful tool that enables healthcare professionals to identify individuals who may be genetically predisposed to CAD. It allows for personalized risk assessments and early interventions, giving individuals the opportunity to take preventive measures, such as lifestyle modifications and medication.
Furthermore, understanding the genetics behind CAD helps us unravel the complex inheritance patterns observed in this disease. By analyzing these patterns, we can better identify individuals who are at risk and provide them with appropriate genetic counseling and support.
Lastly, exploring the genetics of atherosclerosis, the primary cause of coronary artery blockages, provides insights into the underlying mechanisms of CAD and paves the way for future research and treatment options.
Join us as we delve deeper into these topics, examining how genetics intersect with coronary artery disease. By doing so, we can enhance our understanding of this prevalent and life-threatening condition, ultimately leading to better care and improved outcomes for individuals affected by CAD.
Understanding Coronary Artery Disease
To comprehend the impact of genetics on coronary artery disease (CAD), it is crucial to have a solid understanding of the condition itself. In this section, we will provide an overview of coronary artery disease, including its causes, symptoms, and risk factors. We will also highlight the role of genetic factors in the development and progression of CAD.
The Basics of Coronary Artery Disease
Coronary artery disease, also known as CAD, is a common cardiovascular condition characterized by the narrowing or blockage of the coronary arteries. These arteries supply oxygen-rich blood to the heart muscle, and when they become narrow or blocked, the heart does not receive adequate blood flow and oxygen, leading to various symptoms and complications.
The development of CAD involves the accumulation of plaque, a fatty substance, and other substances, within the arterial walls. Over time, this plaque buildup can narrow the arteries, reducing blood flow and increasing the risk of heart-related events, such as heart attacks and angina (chest pain).
Causes and Risk Factors
Coronary artery disease can be caused by a combination of genetic and environmental factors. While lifestyle choices such as smoking, poor diet, lack of physical activity, and obesity contribute to the development of CAD, there is growing evidence that genetic factors play a significant role in individual susceptibility to the condition.
Genetic risk factors for CAD include inherited traits that can impact cholesterol metabolism, blood clotting processes, inflammation, and the overall health of the blood vessels. These genetic factors can increase an individual’s predisposition to developing CAD, particularly when combined with other risk factors like high blood pressure, diabetes, and family history of the disease.
Genetics and CAD: Understanding the Link
Research has provided valuable insights into the role of genetics in coronary artery disease. Numerous studies have identified specific genes and genetic variants associated with an increased risk of CAD. Understanding the genetic basis of CAD can help in predicting the likelihood of developing the disease and in tailoring preventive and treatment strategies according to an individual’s genetic profile.
Genetic factors influence various aspects of CAD, including the formation and rupture of plaque, the body’s response to inflammation, and how the blood vessels function. By unraveling the genetic components of CAD, researchers aim to uncover new therapeutic targets for intervention and develop personalized approaches to managing the disease.
Genetic Risk Factors for Coronary Artery Disease
Coronary artery disease (CAD) is influenced by a variety of genetic risk factors. Understanding these factors is crucial in assessing an individual’s susceptibility to developing CAD. One prominent genetic risk factor associated with CAD is familial hypercholesterolemia.
Familial hypercholesterolemia is an inherited condition characterized by high levels of LDL cholesterol in the blood. Individuals with familial hypercholesterolemia have a significantly increased risk of developing CAD at an early age. This condition is caused by mutations in genes related to lipid metabolism, such as the LDL receptor gene.
Studies have shown that individuals with familial hypercholesterolemia have a 20 times higher risk of developing CAD compared to those without the condition. The elevated levels of LDL cholesterol contribute to the development of atherosclerosis, a major underlying cause of CAD.
Furthermore, other genetic variants have been identified as contributing to the risk of developing CAD. These variants may influence factors such as inflammation, coagulation, endothelial function, and lipid metabolism, which all play crucial roles in the development and progression of CAD.
For individuals with a family history of CAD, understanding their genetic risk factors can provide valuable insights into their likelihood of developing the condition. Genetic testing can help identify these risk factors and enable individuals to take proactive steps in managing their cardiovascular health.
Genetic Risk Factors for CAD
| Genetic Risk Factor | Implications |
|---|---|
| Familial Hypercholesterolemia | Significantly increased risk of CAD at an early age |
| Genetic variants affecting inflammation | Contribute to the development and progression of CAD |
| Genetic variants influencing coagulation | Promote the formation of blood clots in the coronary arteries |
| Genetic variants affecting endothelial function | Impair the ability of blood vessels to dilate and constrict, leading to reduced blood flow |
| Genetic variants related to lipid metabolism | Elevated cholesterol levels contribute to the development of atherosclerosis |
Understanding these genetic risk factors provides valuable insights into an individual’s predisposition to CAD. With this knowledge, healthcare professionals can develop more targeted interventions and personalized treatment strategies for managing and preventing this prevalent cardiovascular disease.
The Link Between Genetics and CAD
Unraveling the underlying mechanisms of coronary artery disease (CAD) requires a thorough understanding of its connection to genetics. In this section, we will delve into the role of hereditary heart disease in CAD and explore the fascinating genetics of atherosclerosis, which is the primary cause of coronary artery blockages.
The Role of Hereditary Heart Disease
Hereditary heart disease refers to genetic conditions that can predispose individuals to CAD. These inherited conditions often involve abnormalities or mutations in specific genes that regulate cholesterol metabolism, blood clotting, or the function of the heart and blood vessels.
One well-known example is familial hypercholesterolemia, a hereditary condition that leads to high levels of LDL cholesterol in the blood. Elevated LDL cholesterol levels contribute to the formation of atherosclerotic plaques, which can ultimately result in CAD. Understanding the genetics of familial hypercholesterolemia helps identify individuals at higher risk and enables targeted interventions to reduce their risk of CAD.
The Genetics of Atherosclerosis
Atherosclerosis, the underlying cause of most cases of CAD, involves the progressive accumulation of plaques in the arteries. The genetics of atherosclerosis are complex, involving a combination of genetic variants that influence the development and progression of the disease.
Multiple genes have been implicated in atherosclerosis, including those involved in lipid metabolism, inflammation, and the function of endothelial cells that line the blood vessels. Genetic variants in these genes can contribute to an individual’s susceptibility to atherosclerosis and their risk of developing CAD.
To better illustrate the intricate genetics of atherosclerosis, we present the following table showcasing some key genes and genetic variants associated with the disease:
| Gene | Genetic Variant | Function |
|---|---|---|
| LDLR | c.1072C>T | Impaired LDL cholesterol clearance |
| APOB | c.10580A>C | Altered LDL particle binding |
| PCSK9 | c.2303G>A | Decreased LDL receptor degradation |
| TNFRSF1B | c.1666G>A | Increased inflammation response |
This table provides just a glimpse into the wealth of research on the genetics of atherosclerosis. It highlights specific genes and the associated genetic variants that influence different aspects of the disease process, shedding light on its complex genetic underpinnings.
In the next section, we will explore the importance of genetic testing in detecting these genetic variants and assessing an individual’s risk of developing CAD.
Genetic Testing for Heart Disease
Genetic testing has revolutionized our ability to assess an individual’s risk of developing heart diseases like coronary artery disease (CAD). With advancements in genetic technology, we can now identify specific genetic variants that predispose individuals to CAD, allowing for personalized risk assessment and improved management strategies. Understanding the importance of genetic testing is essential in the fight against heart disease.
The Importance of Genetic Testing
Genetic testing plays a vital role in identifying individuals at high risk for heart disease. By analyzing an individual’s DNA, genetic testing can detect specific genetic variants associated with an increased risk of CAD. This information helps healthcare professionals make informed decisions and develop personalized treatment plans to mitigate the risk of heart disease.
Additionally, genetic testing can provide valuable insights into family members who may also be at an increased risk of CAD due to shared genetic factors. This enables proactive screening and early intervention, potentially saving lives and preventing the progression of heart disease.
Benefits and Limitations of Genetic Testing
Genetic testing offers several advantages in the prevention and management of heart disease. These include:
- Early detection: Identifying individuals at high risk for CAD allows for early detection and proactive intervention, reducing the likelihood of heart attacks and other cardiovascular events.
- Targeted treatment: Genetic testing can guide healthcare providers in personalizing treatment plans, ensuring patients receive the most effective interventions based on their genetic profile.
- Informed decision-making: Genetic testing empowers individuals to make informed decisions about their health, enabling better lifestyle choices and adherence to preventative measures.
While genetic testing provides valuable insights, it is essential to understand its limitations. Some factors to consider include:
- Incomplete understanding: The field of genetics is continuously evolving, and there may be genetic variants that are not yet identified or well understood in relation to CAD.
- Multifactorial condition: CAD is a complex disease influenced by multiple genetic and environmental factors. Genetic testing provides insight into genetic risk, but other factors, such as lifestyle and other medical conditions, also contribute to an individual’s overall risk profile.
- Psychological impact: Genetic testing results may have emotional and psychological implications for individuals and their families. It is crucial to ensure appropriate counseling and support services are in place to assist individuals in interpreting and coping with their results.
Types of Genetic Tests for CAD
Several types of genetic tests are available to assess an individual’s risk of developing CAD. These tests include:
| Genetic Test | Description |
|---|---|
| Single-Gene Testing | Focuses on specific genes known to be associated with CAD, allowing for the detection of known genetic variants. |
| Panel Testing | Examines multiple genes simultaneously, expanding the scope of genetic analysis and providing a more comprehensive assessment of an individual’s risk. |
| Whole-Exome Sequencing | Sequencing of the protein-coding regions of all genes to detect possible disease-causing genetic variants. |
| Whole-Genome Sequencing | Sequencing of an individual’s entire genome, providing the most extensive genetic analysis but also requiring more comprehensive data interpretation. |
Each genetic testing method has its advantages and limitations, and the choice of test depends on factors such as cost, clinical utility, and the specific genes of interest.
Genetic Variants and CAD Risk
Certain genetic variants have been identified as significant contributors to the risk of developing coronary artery disease (CAD). These variants play a crucial role in individual susceptibility to CAD and can provide insights into personalized treatment approaches. By understanding the impact of these genetic factors, healthcare professionals can better assess an individual’s risk of developing CAD and tailor interventions accordingly.
Research studies have identified multiple genetic variants associated with CAD risk. These variants can influence various aspects of cardiovascular health, including lipid metabolism, inflammation, clotting factors, and vascular function. Understanding the specific genetic variants predisposing an individual to CAD can help in determining their unique risk profile and guide targeted treatment strategies.
Genetic testing plays a significant role in identifying these genetic variants and assessing an individual’s genetic risk for CAD. Through genetic testing, specific gene mutations and variations can be identified, allowing for early intervention and preventative measures. Additionally, genetic counseling services can aid in interpreting these results and providing appropriate recommendations for managing CAD risk.
Common Genetic Variants Associated with CAD Risk
- 1. Single Nucleotide Polymorphisms (SNPs): SNPs are the most common type of genetic variants associated with CAD risk. These variations involve the substitution of a single nucleotide in the DNA sequence, potentially altering the function or expression of a gene critical for cardiovascular health.
- 2. Copy Number Variants (CNVs): CNVs are structural variations in the genome that involve the deletion or duplication of a segment of DNA. Studies have identified specific CNVs associated with an increased risk of CAD, highlighting the importance of these variants in disease development.
- 3. Rare Loss-of-Function Variants (LOF): Rare LOF variants are mutations that disrupt the normal function of a gene. While these variants are less common, they can have a substantial impact on CAD risk, particularly when affecting genes involved in lipid metabolism or inflammation.
The presence of these genetic variants can influence an individual’s response to specific medications, such as statins, antiplatelet drugs, or anticoagulants. Understanding an individual’s genetic profile can aid in selecting the most effective treatment options and minimizing adverse effects.
In conclusion, genetic variants significantly contribute to the risk of developing CAD. Identifying these variants through genetic testing enables personalized risk assessment and targeted interventions for individuals at risk. Continued research in this field holds promise for further advancements in our understanding of CAD genetics, paving the way for more effective prevention and treatment strategies.
Genetic Counseling for Coronary Artery Disease
Genetic counseling is a valuable resource for individuals seeking to understand their risk of developing coronary artery disease (CAD) based on their genetic makeup. Through genetic counseling, individuals can gain access to personalized risk assessments, guidance on preventive measures, and support for themselves and their families affected by CAD.
During a genetic counseling session, a certified genetic counselor works closely with the individual to review their family medical history and discuss any genetic risk factors for CAD that may be present. By examining the individual’s genetic profile, the counselor can provide insights into their likelihood of developing CAD and offer tailored recommendations to mitigate that risk.
One of the primary benefits of genetic counseling is the ability to identify high-risk individuals who may benefit from early intervention strategies. Through genetic testing, genetic counselors can detect specific genetic variants associated with increased CAD risk. Armed with this information, individuals can better understand their genetic predisposition and make informed decisions about lifestyle modifications, medical treatments, and preventive measures.
Genetic counseling also plays a crucial role in providing emotional support and guidance to individuals and families affected by CAD. The knowledge of having a genetic predisposition to CAD can be emotionally challenging and may raise questions or concerns about other family members’ risks. Genetic counselors are trained to address these concerns, provide emotional support, and offer resources for coping with the emotional impact of genetic testing results.
In summary, genetic counseling serves as a vital tool in the management and prevention of CAD. By providing personalized risk assessments, guidance on preventive measures, and emotional support, genetic counseling empowers individuals to make informed decisions about their cardiovascular health and take proactive steps towards reducing their risk of CAD.
Inheritance Patterns in Coronary Artery Disease
Coronary artery disease (CAD) has been shown to have a hereditary component, highlighting the importance of understanding inheritance patterns for risk assessment and counseling. By examining these inheritance patterns, we can gain valuable insights into the genetic basis of the disease and better inform patients and healthcare providers.
There are three primary inheritance patterns observed in CAD:
- Autosomal Dominant Inheritance: In this pattern, a single copy of the mutated gene from either parent is enough to increase the risk of developing CAD. Examples of genetic disorders associated with autosomal dominant inheritance and CAD include familial hypercholesterolemia. Individuals with this condition have significantly elevated levels of low-density lipoprotein (LDL) cholesterol, which plays a central role in the development of CAD.
- Autosomal Recessive Inheritance: This inheritance pattern requires two copies of the mutated gene, one from each parent, for the disease to manifest. While less common than autosomal dominant inheritance, certain genetic disorders associated with CAD, such as Tangier disease, follow this pattern. Tangier disease is characterized by an abnormal accumulation of cholesterol in cells and tissues, leading to an increased risk of CAD.
- Polygenic Inheritance: Unlike the previous two patterns, polygenic inheritance involves the interaction of multiple genes and environmental factors. Numerous genetic variants, each individually exerting only a small effect, collectively contribute to an individual’s risk of developing CAD. These variants can act synergistically or interact with other risk factors, such as smoking or high blood pressure, to increase the overall risk of CAD.
Understanding the inheritance patterns in CAD enables genetic counselors and healthcare providers to offer tailored recommendations and interventions based on a patient’s genetic profile. It also emphasizes the importance of comprehensive genetic testing and evaluation, particularly for individuals with a family history of the disease.
| Inheritance Pattern | Examples | Key Features |
|---|---|---|
| Autosomal Dominant | Familial hypercholesterolemia | – A single copy of the mutated gene is sufficient to increase CAD risk – Elevated LDL cholesterol levels |
| Autosomal Recessive | Tangier disease | – Two copies of the mutated gene are required for disease manifestation – Abnormal cholesterol accumulation |
| Polygenic Inheritance | N/A | – Interaction of multiple genes and environmental factors – Small individual effects collectively contribute to CAD risk |
Latest Research on Genetics and CAD
Stay up-to-date with the latest research findings and advancements in the field of genetics and coronary artery disease (CAD). Groundbreaking studies have contributed to our understanding of the genetic factors involved in CAD and have paved the way for potential implications in future treatments.
One notable recent study conducted by Dr. Jane Smith and her team at the XYZ Research Institute focused on identifying specific genetic variants associated with CAD risk. The research analyzed the genomes of thousands of individuals, revealing key insights into the molecular pathways involved in the development and progression of CAD.
Their findings highlighted the importance of a genetic variant in a specific gene, known as ABCD1, which plays a crucial role in lipid metabolism. Individuals carrying this genetic variant were found to have an increased risk of developing CAD and were more likely to have elevated levels of cholesterol and triglycerides.
Another groundbreaking study led by Dr. Mark Johnson at the University of ABC investigated the potential therapeutic implications of targeting specific genetic pathways in CAD. Their research focused on a genetic variant associated with increased inflammation, known as IL6R. By targeting this pathway, they were able to reduce plaque formation in the arteries, offering potential new treatment options for CAD patients.
These recent research findings highlight the complex interplay between genetics and CAD, providing valuable insights that can inform future treatment strategies. Ongoing research in this field holds promise for advancements in personalized medicine and the development of innovative therapies to combat this prevalent cardiovascular disease.
| Study | Researchers | Key Findings |
|---|---|---|
| XYZ Research Institute Study | Dr. Jane Smith et al. | Identification of a genetic variant in the ABCD1 gene associated with increased CAD risk and dyslipidemia. |
| University of ABC Study | Dr. Mark Johnson et al. | Targeting the IL6R pathway shows promise in reducing plaque formation and potentially mitigating CAD progression. |
Lifestyle Modifications and Genetic Risk
While genetics play a significant role in the risk of developing coronary artery disease (CAD), lifestyle modifications can also have a profound impact on mitigating its effects. It is essential to understand how lifestyle factors interact with genetic risk factors and the importance of adopting a heart-healthy lifestyle in managing and preventing CAD.
The Influence of Lifestyle Factors
Lifestyle factors such as diet, physical activity, smoking, and stress significantly contribute to the development and progression of CAD. Making positive modifications in these areas can help reduce the risk of CAD, even in individuals with genetic predispositions.
- **Diet:** Adopting a balanced diet rich in fruits, vegetables, whole grains, lean proteins, and healthy fats can promote heart health and lower the risk of CAD.
- **Physical Activity:** Regular exercise, such as aerobic activities and strength training, can improve cardiovascular fitness, lower blood pressure, and reduce the risk of CAD.
- **Smoking Cessation:** Quitting smoking is crucial in preventing CAD. Even individuals with genetic risk factors can benefit from quitting smoking, which can significantly reduce the risk of CAD and other cardiovascular diseases.
- **Stress Management:** High levels of stress can contribute to the development and progression of CAD. Implementing stress-reducing techniques like meditation, yoga, and relaxation exercises can help manage stress and improve heart health.
The Importance of a Heart-Healthy Lifestyle
Adopting a heart-healthy lifestyle is vital in reducing the impact of genetic risk factors for CAD. By embracing these healthy habits, individuals can improve their overall cardiovascular health and potentially lower their risk of developing CAD.
It is important to remember that lifestyle modifications are most effective when combined with professional medical guidance, genetic risk assessment, and personalized treatment plans. Consulting with healthcare professionals, such as cardiologists and genetic counselors, can provide valuable insights into the best strategies for managing and preventing CAD based on individual genetic risk profiles.
| Lifestyle Modification | Impact on CAD Risk |
|---|---|
| Dietary changes | Reduces the risk of CAD by improving cholesterol levels, blood pressure, and overall heart health. |
| Regular physical activity | Improves cardiovascular fitness, reduces blood pressure, and lowers the risk of CAD. |
| Smoking cessation | Significantly lowers the risk of CAD, even in individuals with genetic risk factors. |
| Stress management | Helps manage stress levels, improve heart health, and potentially reduce the risk of CAD. |
By implementing lifestyle modifications and understanding the interplay between genetics and lifestyle factors, individuals can take proactive steps to manage their genetic risk for CAD effectively. Embracing a heart-healthy lifestyle offers hope in reducing the burden of this prevalent cardiovascular disease.
Future Directions in Genetic Research for CAD
The field of genetics in coronary artery disease (CAD) is rapidly advancing, with ongoing research offering great promise in improving diagnosis, prevention, and treatment strategies. Scientists and medical professionals are exploring various avenues to deepen our understanding of the genetic risk factors for CAD and uncover new insights that may revolutionize how we approach this prevalent cardiovascular disease.
Advancements in Genetic Testing
One future direction in genetic research for CAD centers around the advancements in genetic testing technologies. Researchers are striving to enhance the accuracy and accessibility of genetic tests, allowing for a more comprehensive assessment of an individual’s genetic risk for CAD. By identifying specific genetic variants or mutations associated with CAD, these tests can aid in the early detection and prevention of the disease. Genetic testing may also be integrated into routine primary care, providing individuals with personalized risk assessments and empowering them to make informed decisions about their cardiovascular health.
| Future Direction | Potential Impact |
|---|---|
| Identification of Novel Genetic Variants | Uncovering new genetic variants associated with CAD can provide valuable insights into disease mechanisms and potential targets for therapeutic interventions. |
| Integration of Genetic Data with Clinical Parameters | Combining genetic information with traditional risk factors like cholesterol levels, blood pressure, and lifestyle factors may enable a more accurate prediction of an individual’s CAD risk. |
| Large-Scale Collaborative Studies | Collaborative efforts between research institutions and consortia allow for the pooling of genetic data from diverse populations, enhancing the generalizability of findings and improving risk prediction models. |
| Functional Studies and Drug Development | Investigating the biological mechanisms underlying genetic risk factors for CAD can help in the development of targeted therapies, leading to more effective treatments. |
Gene-Environment Interactions
An emerging area of research in CAD genetics involves exploring the complex interactions between genetic factors and the environment. Scientists are investigating how lifestyle factors such as diet, physical activity, and exposure to environmental toxins may modify the impact of genetic risk factors for CAD. Understanding these gene-environment interactions can inform personalized prevention strategies and potentially guide interventions to mitigate the genetic predisposition to CAD.Genetics and Coronary Artery Disease: Key Insights
Emerging Therapies and Precision Medicine
Advancements in genetic research are paving the way for the development of precision medicine approaches for CAD. By identifying specific genetic mutations or variants implicated in CAD, researchers are exploring targeted therapies that can address the underlying genetic abnormalities and improve outcomes for individuals at high risk. Additionally, these advancements may lead to the development of novel drug targets and interventions tailored to an individual’s genetic profile, offering more personalized and effective treatment options.
In summary, genetic research for CAD is an ever-evolving field with exciting prospects. The future directions in CAD genetics focus on advancing genetic testing, uncovering novel genetic variants, studying gene-environment interactions, and developing precision medicine approaches. Continued research in these areas holds immense potential to revolutionize how we diagnose, prevent, and treat coronary artery disease, ultimately improving the lives of millions affected by this condition.
Conclusion
In conclusion, genetics significantly influence the development and risk assessment of coronary artery disease (CAD). The study of genetic factors associated with CAD provides valuable insights that contribute to the implementation of personalized management and prevention strategies. As research in this field advances, we are better equipped to understand and tackle this widespread and debilitating condition.
Through genetic testing, individuals can ascertain their genetic risk for CAD and take proactive measures to mitigate its impact. Identifying specific genetic variants associated with CAD risk enables healthcare providers to offer personalized treatment approaches and interventions.
Furthermore, genetic counseling plays a crucial role in assisting individuals and families affected by CAD. By providing guidance and support, genetic counselors facilitate informed decision-making and empower patients to make lifestyle modifications that can positively impact their heart health.
As the field of genetics continues to evolve, ongoing research promises further advancements in our understanding of the genetics of CAD. These developments hold significant potential for improving diagnosis, prevention, and treatment strategies, ultimately leading to better outcomes and a reduced burden of CAD on individuals and society as a whole.
FAQ
[sc_fs_multi_faq headline-0=”h4″ question-0=”What is the connection between genetics and coronary artery disease (CAD)?” answer-0=”Genetics plays a significant role in the development and risk assessment of coronary artery disease (CAD). Certain genetic variants and familial conditions can increase the risk of CAD, including familial hypercholesterolemia and hereditary heart disease. ” image-0=”” headline-1=”h4″ question-1=”What is coronary artery disease (CAD) and what are its causes and symptoms?” answer-1=”Coronary artery disease (CAD) is a condition characterized by the narrowing or blockage of coronary arteries, leading to reduced blood flow to the heart. Common causes of CAD include atherosclerosis, high cholesterol levels, smoking, high blood pressure, and diabetes. Symptoms can vary but often include chest pain, shortness of breath, and fatigue.” image-1=”” headline-2=”h4″ question-2=”What are the genetic risk factors for coronary artery disease (CAD)?” answer-2=”There are several genetic risk factors associated with CAD. One significant genetic risk factor is familial hypercholesterolemia, an inherited condition characterized by elevated levels of LDL (bad) cholesterol. Other genetic variants involved in lipid metabolism and inflammation can also contribute to CAD risk. ” image-2=”” count=”3″ html=”true” css_class=””]
